Reviewing Endologix and DENTSPLY SIRONA

Comparing the medical device companies to determine the better investment

Published on Feb. 7, 2026

Got story updates? Submit your updates here. ›

Endologix (OTCMKTS:ELGXQ) and DENTSPLY SIRONA (NASDAQ:XRAY) are both medical device companies, but which one is the better investment? This article compares the two companies based on factors like risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, and valuation.

Why it matters

As investors look to diversify their portfolios with healthcare and medical technology stocks, understanding the relative strengths and weaknesses of Endologix and DENTSPLY SIRONA can help inform their investment decisions. The analysis provides insight into the competitive landscape and growth prospects of these two medical device firms.

The details

The article notes that DENTSPLY SIRONA has a stronger consensus rating from analysts and a higher potential upside compared to Endologix. It also highlights that DENTSPLY SIRONA has higher revenue but lower earnings per share than Endologix. Additionally, DENTSPLY SIRONA has stronger institutional ownership at 95.7% versus 1.3% for Endologix, indicating greater confidence from large investors. The article concludes that DENTSPLY SIRONA outperforms Endologix on 7 out of 9 factors compared.

  • The article was published on February 7, 2026.

The players

Endologix, Inc.

A medical device company that develops, manufactures, and sells products for the treatment of abdominal aortic aneurysms.

DENTSPLY SIRONA Inc.

A global dental products and technologies company that manufactures and sells various dental equipment, consumables, and solutions worldwide.

Got photos? Submit your photos here. ›

The takeaway

This analysis suggests that DENTSPLY SIRONA may be the more favorable investment compared to Endologix based on its stronger consensus rating, higher potential upside, greater institutional ownership, and outperformance on key financial and operational metrics. Investors looking to gain exposure to the medical device sector may want to further research DENTSPLY SIRONA as a potential addition to their portfolios.